Cadila Pharma to build plant at Astrakhan

Gujarat based pharmaceutical company informed BSE that its board and the Board of Directors of ZAHL, LHL and ZPL reached the conclusion at their respective meetings held on April 22. has approved the merger of (ZAHL), (LHL) and Zydus Pharmaceuticals ...

If the recently notified Drugs (Price Control) Order, 2013 spells good news for patients, it certainly causes worry lines for pharma companies, who say their profitability and margins will be affected in the immediate term. As per the order, prices ...

Cadila Healthcare has declared the first day launch of Zolmitriptan orally disintegrating tablets upon receiving the final approval from the US Food and Drug Administrator (USFDA). The drug is used in the treatment of migraine, has an estimated sale ...

Shares of drug makers fell on Monday, after the government notified a new pricing policy designed to cap the prices of a greater number of formulations. The BSE's healthcare index fell 1.8 per cent, against the Sensex's 0.3 per cent fall, as ...

Related to : Ranbaxy Laboratories Ltd Ranbaxy Laboratories Ltd BSE 20 May 13 | 03:34 PM 444.15 -27.3 (-5.79%) NSE 20 May 13 | 03:31 PM 443.60 -27.9 (-5.92%) Shares of pharmaceutical companies are under pressure in noon deals trades and declined ...

After a phase of low growth (Nov 2012-March 2013), domestic pharmaceutical market has shown some signs of recovery with 9.7% growth for the month of April 2013 versus 5.6% in March 2013. Most stocks under coverage posted growth in-line with market. Amongst ...

With another financial year ending, pharmaceutical companies have seen huge growth in their market capitalisation. The top 10 stocks (by market cap) showed about 40 per cent growth last year. Though some stocks such as Ranbaxy, GSK Pharma and Cadila ...

Local drug makers are increasingly looking at tapping another off-patent opportunity, that of biosimilars. These can be called the generic version of biologics or drugs that are derived from living organisms or organic substances. Pharma companies ...

Hiring activity up by 14 per cent in March 13 over Feb 13 The pharmaceutical sector is likely to drive the hiring growth in 2013. The sector has emerged as a powerful employer with the hiring activity being up by 14 per cent in March 13 over Feb 13.